JP2024535852A5 - - Google Patents

Info

Publication number
JP2024535852A5
JP2024535852A5 JP2024516862A JP2024516862A JP2024535852A5 JP 2024535852 A5 JP2024535852 A5 JP 2024535852A5 JP 2024516862 A JP2024516862 A JP 2024516862A JP 2024516862 A JP2024516862 A JP 2024516862A JP 2024535852 A5 JP2024535852 A5 JP 2024535852A5
Authority
JP
Japan
Prior art keywords
dsrna agent
angptl4
subject
nucleotides
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024516862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535852A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076613 external-priority patent/WO2023044458A1/en
Publication of JP2024535852A publication Critical patent/JP2024535852A/ja
Publication of JP2024535852A5 publication Critical patent/JP2024535852A5/ja
Pending legal-status Critical Current

Links

JP2024516862A 2021-09-17 2022-09-16 ＡＮＧＰＴＬ４をサイレンシングするためのｉＲＮＡ組成物および方法 Pending JP2024535852A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163245693P 2021-09-17 2021-09-17
US63/245,693 2021-09-17
US202263317480P 2022-03-07 2022-03-07
US63/317,480 2022-03-07
PCT/US2022/076613 WO2023044458A1 (en) 2021-09-17 2022-09-16 Irna compositions and methods for silencing angptl4

Publications (2)

Publication Number Publication Date
JP2024535852A JP2024535852A (ja) 2024-10-02
JP2024535852A5 true JP2024535852A5 (https=) 2025-11-06

Family

ID=85603655

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024516862A Pending JP2024535852A (ja) 2021-09-17 2022-09-16 ＡＮＧＰＴＬ４をサイレンシングするためのｉＲＮＡ組成物および方法

Country Status (4)

Country Link
US (1) US20250136978A1 (https=)
EP (1) EP4402261A1 (https=)
JP (1) JP2024535852A (https=)
WO (1) WO2023044458A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119343148A (zh) * 2022-06-10 2025-01-21 南洋理工大学 使用angptl4拮抗剂治疗肝纤维化、炎症或相关疾病的方法
CN120019148A (zh) * 2023-08-22 2025-05-16 成都先衍生物技术有限公司 一种靶向ANGPTL4的siRNA及其缀合物和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030194704A1 (en) * 2002-04-03 2003-10-16 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
CN115927335A (zh) * 2015-04-13 2023-04-07 阿尔尼拉姆医药品有限公司 类血管生成素3（ANGPTL3）iRNA组合物及其使用方法
CA3164050A1 (en) * 2019-12-09 2021-06-17 Empirico Inc. Oligonucleotides for treatment of angiopoietin like 4 (angptl4) related diseases

Similar Documents

Publication Publication Date Title
JP2021518125A5 (https=)
JP2024515423A5 (https=)
JP2023529903A5 (https=)
JP2022501040A5 (https=)
HRP20200672T1 (hr) RNAi SREDSTVA, PRIPRAVCI I POSTUPCI NJIHOVE UPOTREBE ZA LIJEČENJE BOLESTI POVEZANIH S TRANSTIRETINOM (TTZ)
JP2023536974A5 (https=)
JP2023550485A5 (https=)
JP2023514336A5 (https=)
TWI881004B (zh) 用於治療ｈｂｖ之靶向ｈｂｖ的治療性寡核苷酸及ｔｌｒ７促效劑之醫藥組合
JP2018536689A5 (https=)
JP2024535852A5 (https=)
HRP20202082T1 (hr) Transtiretin (ttr) irna pripravci i postupci njihove upotrebe za liječenje ili sprječavanje bolesti povezanih s ttr
JP2018523655A5 (https=)
JP2024514880A5 (https=)
JP2023506258A5 (https=)
JP2023516095A5 (https=)
JP2024516356A5 (https=)
JP2024508896A5 (https=)
JP2024522996A5 (https=)
WO2022068923A1 (zh) 血管生成素样3(ANGPTL3)的siRNA及其用途
JP2024538859A5 (https=)
JP2025524740A (ja) オリゴヌクレオチド送達増強剤、医薬組成物およびそれらを使用する方法
JP2024528701A5 (https=)
CN114729360A (zh) 降低病毒分子水平的方法
KR20240101580A (ko) Hbv 치료를 위한 약학 조합물